114 related articles for article (PubMed ID: 26050881)
1. Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo.
Jiang Z; Han B; Li H; Yang Y; Liu W
Carbohydr Polym; 2015 Sep; 129():1-8. PubMed ID: 26050881
[TBL] [Abstract][Full Text] [Related]
2. Preparation and anti-tumor metastasis of carboxymethyl chitosan.
Jiang Z; Han B; Li H; Li X; Yang Y; Liu W
Carbohydr Polym; 2015 Jul; 125():53-60. PubMed ID: 25857959
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
Chi J; Jiang Z; Qiao J; Peng Y; Liu W; Han B
Carbohydr Polym; 2019 Jun; 214():80-89. PubMed ID: 30926011
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis.
Wei A; Zhou D; Ruan J; Cai Y; Xiong C; Wu G
J Ethnopharmacol; 2012 Jan; 139(2):373-80. PubMed ID: 22123201
[TBL] [Abstract][Full Text] [Related]
5. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and antimetastasis effects of macerating solutions from an injectable chitosan-based hydrogel on hepatocarcinoma.
Wang H; Song F; Chen Q; Hu R; Jiang Z; Yang Y; Han B
J Biomed Mater Res A; 2015 Dec; 103(12):3879-85. PubMed ID: 26123792
[TBL] [Abstract][Full Text] [Related]
7. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
8. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
Jung KH; Zheng HM; Jeong Y; Choi MJ; Lee H; Hong SW; Lee HS; Son MK; Lee S; Hong S; Hong SS
Cancer Lett; 2013 Jan; 328(1):176-87. PubMed ID: 22902995
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
11. Total alkaloids of Rubus alceifolius Poir shows anti-angiogenic activity in vivo and in vitro.
Zhao J; Lin W; Zhuang Q; Zhong X; Cao Z; Hong Z; Peng J
Integr Cancer Ther; 2014 Nov; 13(6):520-8. PubMed ID: 25148840
[TBL] [Abstract][Full Text] [Related]
12. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
[TBL] [Abstract][Full Text] [Related]
13. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Huynh H; Ong R; Soo KC
Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
[TBL] [Abstract][Full Text] [Related]
14. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
Chi J; Jiang Z; Chen X; Peng Y; Liu W; Han B; Han B
Carbohydr Polym; 2019 Dec; 226():115297. PubMed ID: 31582090
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Eupolyphaga fibrinolytic protein on microvessel density and the expression of vascular endothelial growth factor in mice tumor].
Cao FC; Han YL; Chen B; Liu H; Ding H; Huang MX; Ye Y
Zhong Yao Cai; 2011 May; 34(5):676-9. PubMed ID: 21954551
[TBL] [Abstract][Full Text] [Related]
16. Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism.
Xu Y; Wen Z; Xu Z
Anticancer Res; 2009 Dec; 29(12):5103-9. PubMed ID: 20044623
[TBL] [Abstract][Full Text] [Related]
17. The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis.
Enomoto H; Tao L; Eguchi R; Sato A; Honda M; Kaneko S; Iwata Y; Nishikawa H; Imanishi H; Iijima H; Tsujimura T; Nishiguchi S
Sci Rep; 2017 Sep; 7(1):12189. PubMed ID: 28939881
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
Liu F; Feng L; Zhang L; Zhang X; Zhang N
Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
[TBL] [Abstract][Full Text] [Related]
19. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
Matsubara M; Shiraha H; Kataoka J; Iwamuro M; Horiguchi S; Nishina S; Takaoka N; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2012 Oct; 27(10):1602-8. PubMed ID: 22554292
[TBL] [Abstract][Full Text] [Related]
20. Evaluation on biological compatibility of carboxymethyl chitosan as biomaterials for antitumor drug delivery.
Jiang Z; Han B; Liu W; Peng Y
J Biomater Appl; 2017 Feb; 31(7):985-994. PubMed ID: 28077049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
